Mihir Raval, MD, MPH, comments on the difference between cold agglutinin disease and other autoimmune hemolytic anemias. Neil Minkoff, MD: Now, you had mentioned that there are other autoimmune ...

Cold antibody hemolytic anemia is a rare autoimmune disorder characterized by the premature destruction of red blood cells by autoantibodies at temperatures of approximately 0 to 10 degrees Celsius. Q ...

/ -- Autoimmune hemolytic anemia (AIHA) treatment encompasses a range of therapeutic strategies aimed at mitigating the immune system's attack on red blood cells, thereby alleviating anemia and ...

Autoimmune hemolytic anemia (AIHA) is a rare but clinically significant disorder in which the immune system mistakenly produces autoantibodies against red blood cells, leading to accelerated ...

In a six-year-old boy with congenital sex-linked hypogammaglobulinemia, Coombs-test positive autoimmune hemolytic anemia developed despite profound deficiencies of immunoglobulins. Direct and indirect ...

Autoimmune hemolytic anemia (AIHA) and paroxysmal nocturnal hemoglobinuria (PNH) are distinct blood disorders with different underlying causes and treatment approaches. Each is rare and potentially ...

July 8, 2005 — Automatic laboratory testing may be of benefit for identifying patients with autoimmune hemolytic anemia (AIHA), according to the results of a study published in the July issue of the ...

"Warm Autoimmune Hemolytic Anemia Market"In 2023, in the 7MM the total wAIHA market size was ~ USD 300 million. Emerging therapies for Warm Autoimmune Hemolytic Anemia, including Obexelimab (ZB012), ...

Rigel Pharmaceuticals, Inc. today announced the publication of data in the American Journal of Hematology from the open label, multicenter, Phase 2 clinical study of fostamatinib in adults with warm ...

CAMBRIDGE, Mass., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat ...

No data regarding hemolytic complications after double UCBT are available in the literature. We report a case of combined auto- and alloimmune hemolysis after double UCBT that proved fatal. A ...